Molina Healthcare, Inc. (NYSE:MOH) Shares Bought by BNP Paribas Arbitrage SA

BNP Paribas Arbitrage SA boosted its holdings in shares of Molina Healthcare, Inc. (NYSE:MOHGet Rating) by 71.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 17,225 shares of the company’s stock after buying an additional 7,203 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Molina Healthcare were worth $5,479,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the business. Great Lakes Advisors LLC lifted its holdings in Molina Healthcare by 7.6% during the 4th quarter. Great Lakes Advisors LLC now owns 4,349 shares of the company’s stock worth $1,383,000 after buying an additional 307 shares in the last quarter. Lazard Asset Management LLC lifted its holdings in Molina Healthcare by 283.8% during the 4th quarter. Lazard Asset Management LLC now owns 13,853 shares of the company’s stock worth $4,406,000 after buying an additional 10,244 shares in the last quarter. UMB Bank N A MO acquired a new stake in Molina Healthcare during the 4th quarter worth approximately $72,000. Argent Capital Management LLC lifted its holdings in Molina Healthcare by 1.7% during the 4th quarter. Argent Capital Management LLC now owns 9,444 shares of the company’s stock worth $3,004,000 after buying an additional 158 shares in the last quarter. Finally, Korea Investment CORP lifted its holdings in Molina Healthcare by 21.1% during the 4th quarter. Korea Investment CORP now owns 17,800 shares of the company’s stock worth $5,662,000 after buying an additional 3,100 shares in the last quarter. Institutional investors own 94.82% of the company’s stock.

A number of research firms have issued reports on MOH. Cowen increased their target price on shares of Molina Healthcare from $356.00 to $366.00 in a report on Monday, May 2nd. BMO Capital Markets raised their price objective on shares of Molina Healthcare from $365.00 to $380.00 and gave the company an “outperform” rating in a report on Monday, February 14th. Mizuho raised their price objective on shares of Molina Healthcare from $330.00 to $345.00 and gave the company a “buy” rating in a report on Friday, February 11th. StockNews.com began coverage on shares of Molina Healthcare in a report on Thursday, March 31st. They issued a “strong-buy” rating on the stock. Finally, Morgan Stanley reduced their price objective on shares of Molina Healthcare from $397.00 to $365.00 and set an “overweight” rating on the stock in a report on Tuesday, February 22nd. One analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $330.95.

In other Molina Healthcare news, Director Steven J. Orlando sold 591 shares of the stock in a transaction on Tuesday, March 8th. The shares were sold at an average price of $311.00, for a total transaction of $183,801.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Ronna Romney sold 195 shares of the stock in a transaction on Tuesday, February 22nd. The shares were sold at an average price of $313.21, for a total transaction of $61,075.95. The disclosure for this sale can be found here. In the last ninety days, insiders sold 6,186 shares of company stock worth $1,944,337. Insiders own 1.49% of the company’s stock.

Shares of NYSE:MOH opened at $295.89 on Friday. The company’s fifty day moving average price is $325.61 and its 200 day moving average price is $309.69. Molina Healthcare, Inc. has a 12 month low of $239.20 and a 12 month high of $350.19. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.44 and a quick ratio of 1.44. The firm has a market capitalization of $17.37 billion, a P/E ratio of 25.18, a P/E/G ratio of 1.04 and a beta of 0.80.

Molina Healthcare (NYSE:MOHGet Rating) last announced its quarterly earnings results on Wednesday, April 27th. The company reported $4.90 EPS for the quarter, topping the consensus estimate of $4.74 by $0.16. Molina Healthcare had a net margin of 2.37% and a return on equity of 31.85%. During the same quarter last year, the company posted $4.44 EPS. On average, sell-side analysts anticipate that Molina Healthcare, Inc. will post 17.14 EPS for the current year.

Molina Healthcare Profile (Get Rating)

Molina Healthcare, Inc provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states.

Featured Articles

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOHGet Rating).

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.